Literature DB >> 16251407

Susceptibility of signal transducer and activator of transcription-1-deficient mice to pulmonary fibrogenesis.

Dianne M Walters1, Aurita Antao-Menezes, Jennifer L Ingram, Annette B Rice, Abraham Nyska, Yoshiro Tani, Steven R Kleeberger, James C Bonner.   

Abstract

The signal transducer and activator of transcription (Stat)-1 mediates growth arrest and apoptosis. We postulated that lung fibrosis characterized by excessive proliferation of lung fibroblasts would be enhanced in Stat1-deficient (Stat1-/-) mice. Two weeks after bleomycin aspiration (3 U/kg), Stat1-/- mice exhibited a more severe fibroproliferative response and significantly elevated total lung collagen compared to wild-type mice. Growth factors [epidermal growth factor (EGF) or platelet-derived growth factor (PDGF)] enhanced [3H]thymidine uptake in lung fibroblasts isolated from Stat1-/- mice compared to wild-type mice. Interferon (IFN)-gamma, which signals growth arrest via Stat1, inhibited EGF- or PDGF-stimulated mitogenesis in wild-type fibroblasts but enhanced [3H]thymidine uptake in Stat1-/- fibroblasts. Moreover, IFN-gamma treatment in the absence of growth factors induced a concentration-dependent increase in [3H]thymidine uptake in Stat1-/- but not wild-type fibroblasts. Mitogen-activated protein kinase (ERK-1/2) phosphorylation in response to PDGF or EGF did not differ among Stat1-/- and wild-type fibroblasts. However, Stat3 phosphorylation induced by PDGF, EGF, or IFN-gamma increased twofold in Stat1-/- fibroblasts compared to wild-type fibroblasts. Our findings indicate that Stat1-/- mice are more susceptible to bleomycin-induced lung fibrosis than wild-type mice due to 1) enhanced fibroblast proliferation in response to growth factors (EGF and PDGF), 2) stimulation of fibroblast growth by a Stat1-independent IFN-gamma signaling pathway, and 3) increased activation of Stat3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251407      PMCID: PMC1603773          DOI: 10.1016/S0002-9440(10)61210-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

Review 1.  Activation of STAT proteins and growth control.

Authors:  J F Bromberg
Journal:  Bioessays       Date:  2001-02       Impact factor: 4.345

2.  Vanadium stimulates human bronchial epithelial cells to produce heparin-binding epidermal growth factor-like growth factor: a mitogen for lung fibroblasts.

Authors:  L Zhang; A B Rice; K Adler; P Sannes; L Martin; W Gladwell; J S Koo; T E Gray; J C Bonner
Journal:  Am J Respir Cell Mol Biol       Date:  2001-02       Impact factor: 6.914

3.  Interferon-gamma elicits arteriosclerosis in the absence of leukocytes.

Authors:  G Tellides; D A Tereb; N C Kirkiles-Smith; R W Kim; J H Wilson; J S Schechner; M I Lorber; J S Pober
Journal:  Nature       Date:  2000-01-13       Impact factor: 49.962

4.  Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.

Authors:  A B Rice; C R Moomaw; D L Morgan; J C Bonner
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

5.  Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases.

Authors:  A Kumar; M Commane; T W Flickinger; C M Horvath; G R Stark
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

6.  The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation.

Authors:  L Didcock; D F Young; S Goodbourn; R E Randall
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Ineffectiveness of interferon-gamma in the treatment of idiopathic myelofibrosis: a pilot study.

Authors:  N Heis-Vahidi-Fard; E Forberg; S Eichinger; A Chott; K Lechner; H Gisslinger
Journal:  Ann Hematol       Date:  2001-02       Impact factor: 3.673

8.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.

Authors:  R Ziesche; E Hofbauer; K Wittmann; V Petkov; L H Block
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

9.  Interferon-gamma modulates lung macrophage production of PDGF-BB and fibroblast growth.

Authors:  A Badgett; J C Bonner; A R Brody
Journal:  J Lipid Mediat Cell Signal       Date:  1996-01

10.  Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1.

Authors:  Y Shen; G Devgan; J E Darnell; J F Bromberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  27 in total

1.  Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.

Authors:  Thiagarajan Venkataraman; Christopher M Coleman; Matthew B Frieman
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

2.  Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation.

Authors:  Matthew J Eagleton; Jun Xu; Mingfang Liao; Brittney Parine; Guy M Chisolm; Linda M Graham
Journal:  J Vasc Surg       Date:  2010-04       Impact factor: 4.268

3.  Chromium(VI) stimulates Fyn to initiate innate immune gene induction in human airway epithelial cells.

Authors:  Antonia A Nemec; Lindsey M Zubritsky; Aaron Barchowsky
Journal:  Chem Res Toxicol       Date:  2010-02-15       Impact factor: 3.739

4.  Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection.

Authors:  Carly Page; Lindsay Goicochea; Krystal Matthews; Yong Zhang; Peter Klover; Michael J Holtzman; Lothar Hennighausen; Matthew Frieman
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

5.  Regulation and activity of secretory leukoprotease inhibitor (SLPI) is altered in smokers.

Authors:  Megan Meyer; Rebecca N Bauer; Blanche D Letang; Luisa Brighton; Elizabeth Thompson; Rosalia C M Simmen; James Bonner; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-27       Impact factor: 5.464

6.  SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.

Authors:  Matthew B Frieman; Jun Chen; Thomas E Morrison; Alan Whitmore; William Funkhouser; Jerrold M Ward; Elaine W Lamirande; Anjeanette Roberts; Mark Heise; Kanta Subbarao; Ralph S Baric
Journal:  PLoS Pathog       Date:  2010-04-08       Impact factor: 6.823

7.  Respiratory syncytial virus infection reduces lung inflammation and fibrosis in mice exposed to vanadium pentoxide.

Authors:  Elizabeth A Turpin; Aurita Antao-Menezes; Mark F Cesta; James B Mangum; Duncan G Wallace; Edilberto Bermudez; James C Bonner
Journal:  Respir Res       Date:  2010-02-22

8.  Mesenchymal cell survival in airway and interstitial pulmonary fibrosis.

Authors:  James C Bonner
Journal:  Fibrogenesis Tissue Repair       Date:  2010-08-25

9.  Host responses to wild-type and attenuated herpes simplex virus infection in the absence of Stat1.

Authors:  Tracy Jo Pasieka; Cristian Cilloniz; Betty Lu; Thomas H Teal; Sean C Proll; Michael G Katze; David A Leib
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

10.  Fibroblast-specific Stat1 deletion enhances the myofibroblast phenotype during tissue repair.

Authors:  Shayna C Medley; Bharath H Rathnakar; Constantin Georgescu; Jonathan D Wren; Lorin E Olson
Journal:  Wound Repair Regen       Date:  2020-03-24       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.